13th May 2024 07:00
Commercial International Bank (Egypt) S.A.E.
Separate Financial Statements
March 31, 2024
Condensed Separate Interim Statement of Financial Position as at March 31, 2024 | |||||
| Notes | Mar. 31, 2024 |
| Dec. 31, 2023 | |
|
| ||||
Assets |
|
|
| ||
Cash and balances at the central bank | 9 | 36,542,863 |
| 71,747,343 | |
Due from banks | 10 | 291,979,960 |
| 230,709,419 | |
Loans and advances to banks, net | 12 | 1,140,170 |
| 822,448 | |
Loans and advances to customers, net | 13 | 268,482,525 |
| 233,824,745 | |
Derivative financial instruments | 1,677,011 |
| 1,101,896 | ||
Financial investments |
|
|
| ||
- Financial Assets at Fair Value through P&L | 14 | 974,297 |
| - | |
- Financial Assets at Fair Value through OCI | 14 | 248,351,476 |
| 232,290,598 | |
- Financial Assets at Amortized cost | 14 | 92,820,896 |
| 37,847,114 | |
- Investments in subsidiaries and associates | 15 | 671,525 |
| 671,525 | |
Non current assets held for sale | 28 | 159,828 |
| 159,828 | |
Other assets | 16 | 24,919,564 |
| 18,929,067 | |
Deferred tax assets | 1,936,004 |
| 1,685,223 | ||
Property and equipment | 17 | 2,703,062 |
| 2,737,936 | |
Total assets |
| 972,359,181 |
| 832,527,142 | |
Liabilities and equity |
|
|
| ||
Liabilities |
|
|
| ||
Due to banks | 18 | 5,572,065 |
| 12,427,384 | |
Due to customers | 19 | 792,409,197 |
| 675,310,076 | |
Derivative financial instruments | 602,480 |
| 140,934 | ||
Current income tax liabilities | 5,445,769 |
| 9,395,534 | ||
Other liabilities | 20 | 29,842,663 |
| 18,307,580 | |
Issued debt instruments | 21 | 4,699,516 |
| 3,073,349 | |
Other loans | 19,184,788 |
| 12,483,907 | ||
Other provisions | 22 | 14,699,408 |
| 11,088,372 | |
Total liabilities |
| 872,455,886 |
| 742,227,136 | |
Equity |
|
|
| ||
Issued and paid up capital | 30,195,010 |
| 30,195,010 | ||
Reserves | 55,513,384 |
| 29,388,626 | ||
Reserve for employee stock ownership plan (ESOP) | 1,786,010 |
| 1,486,010 | ||
Retained earnings * | 12,408,891 |
| 29,230,360 | ||
Total equity and net profit for the period / year |
| 99,903,295 |
| 90,300,006 | |
Total liabilities and equity |
| 972,359,181 |
| 832,527,142 | |
The accompanying notes are an integral part of these financial statements. |
| ||||
( Limited Review report attached ) |
| ||||
* | Including net profit for the period |
| |||
Hussein Abaza | Hisham Ezz Al-Arab | ||||
| CEO & Managing Director | Chairman |
Condensed Separate Interim Income Statement for the period ended March 31, 2024 | ||||||||
| ||||||||
Notes | Mar. 31, 2024 |
| Mar. 31, 2023 | |||||
|
| |||||||
|
| |||||||
Interest and similar income | 36,544,341 |
| 19,729,848 | |||||
Interest and similar expense | (17,784,185) |
| (8,897,778) | |||||
Net interest income |
| 18,760,156 |
| 10,832,070 | ||||
|
| |||||||
Fee and commission income | 2,684,283 |
| 2,004,350 | |||||
Fee and commission expense | (1,118,950) |
| (792,102) | |||||
Net fee and commission income |
| 1,565,333 |
| 1,212,248 | ||||
|
| |||||||
Dividend income | 610 |
| 32,362 | |||||
Net trading income | 6 | 16,202,679 |
| 1,845,604 | ||||
Profits (Losses) on financial investments | 14.1 | 224,271 |
| 70,920 | ||||
Administrative expenses | (2,840,462) |
| (2,004,617) | |||||
Other operating income (expenses) | 7 | (14,923,188) |
| (1,969,625) | ||||
Impairment release (charges) for credit losses | (1,482,187) |
| (947,656) | |||||
Profit before income tax |
| 17,507,212 |
| 9,071,306 | ||||
|
| |||||||
Income tax expense | 26 | (5,722,492) |
| (2,264,671) | ||||
Deferred tax assets (Liabilities) | 26 | 161,877 |
| (722,182) | ||||
Net profit for the period |
| 11,946,597 |
| 6,084,453 | ||||
|
| |||||||
Earnings per share | 8 |
|
| |||||
Basic | 3.50 |
| 1.78 | |||||
Diluted | 3.46 |
| 1.76 | |||||
|
| |||||||
Hussein Abaza |
| Hisham Ezz Al-Arab | ||||||
CEO & Managing Director |
| Chairman |
Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2024 | |||||||
| |||||||
Mar. 31, 2024 |
| Mar. 31, 2023 | |||||
|
| ||||||
|
| ||||||
Net profit for the period |
| 11,946,597 |
| 6,084,453 | |||
|
| ||||||
Change in fair value of Financial invesments measured at fair value through comprehensive income after tax | 1,977,715 |
| (8,507,038) | ||||
Transferred to RE from financial assets at fair value through comprehensive income | - |
| (1,895) | ||||
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income | 745,406 |
| 208,250 | ||||
Total comprehensive income for the period |
| 14,669,718 |
| (2,216,230) |
Condensed Separate Interim Cash Flows for the period ended March 31, 2024 | |||||
| |||||
Notes | Mar. 31, 2024 |
| Mar. 31, 2023 | ||
|
| ||||
Cash flow from operating activities |
|
|
| ||
Profit before income tax | 17,507,212 |
| 9,071,306 | ||
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| ||
Fixed assets depreciation | 17 | 261,427 | 206,400 | ||
Impairment Release/charge for credit losses (Loans and advances to customers and banks) | 1,772,387 | 714,714 | |||
Other provisions Release/charge | 22 | 40,759 | 464,368 | ||
Impairment Release/charge for credit losses (due from banks) | (53) | (1,549) | |||
Impairment Release/charge for credit losses (financial investments) | (290,147) | 234,491 | |||
Impairment Release/charge for other assets | (4,782) | - | |||
Exchange revaluation differences for financial assets at fair value through OCI and AC | (17,328,576) | (6,033,831) | |||
Revaluation differences Impairment charge for Financial Assets at Fair value through OCI | 1,130,412 | - | |||
Revaluation differences Impairment charge for Financial Assets at Amortized cost | 95,225 | - | |||
Revaluation differences Impairment charge for due from banks | 101 | - | |||
Utilization of other provisions | 22 | (297) | (345) | ||
Other provisions no longer used | 22 | (4,220) | - | ||
Exchange revaluation differences of other provisions | 22 | 3,574,794 | 1,169,894 | ||
Profits/losses from selling property and equipment | - | (118) | |||
Profits/losses from selling financial investments at fair value through OCI | 14.1 | (224,271) | (70,920) | ||
Share based payments | 300,000 | 190,974 | |||
Operating profits before changes in operating assets and liabilities |
| 6,829,971 |
| 5,945,384 | |
|
| ||||
Net decrease / increase in assets and liabilities |
|
|
| ||
Due from banks | 42,289,034 | 12,102,385 | |||
Financial assets at fair value through P&L | (974,297) | - | |||
Derivative financial instruments | 154,638 | (358,715) | |||
Loans and advances to banks and customers | 12-13 | (36,747,889) | (17,757,613) | ||
Other assets | (5,850,432) | (75,936) | |||
Due to banks | 18 | (6,855,319) | 4,811,010 | ||
Due to customers | 19 | 117,099,122 | 43,988,897 | ||
Current income tax obligations paid | (276,723) | (272,736) | |||
Other liabilities | 1,851,912 | (362,831) | |||
Net cash generated from (used in) operating activities |
| 117,520,017 |
| 48,019,845 | |
|
| ||||
Cash flow from investing activities |
|
|
| ||
Proceeds from sale of investments in associates | 4,782 | - | |||
Payments for investment in subsidiaries | - | (1,216,022) | |||
Payment for purchases of property, equipment and branches construction | (366,618) | (415,435) | |||
Proceeds from selling property and equipment | - | 118 | |||
Proceeds from redemption of financial assets at amortized cost | 285,507 | 196,783 | |||
Payment for purchases of financial assets at amortized cost | (53,240,480) | (8,454,232) | |||
Payment for purchases of financial assets at fair value through OCI | (26,284,875) | (32,426,908) | |||
Proceeds from selling financial assets at fair value through OCI | 26,380,625 | 46,782,676 | |||
Net cash generated from (used in) investing activities |
| (53,221,059) | 4,466,980 | ||
Condensed Separate Interim Cash Flows for the period ended March 31, 2024 (Cont.) | |||||
| |||||
Mar. 31, 2024 |
| Mar. 31, 2023 | |||
|
| ||||
Cash flow from financing activities |
|
|
| ||
Other loans | 6,700,881 | 1,607,404 | |||
Dividends paid | (5,078,792) | (1,964,603) | |||
Issued debt instruments | 1,626,167 | 612,624 | |||
Capital increase | - | 165,429 | |||
Net cash generated from (used in) financing activities |
| 3,248,256 | 420,854 | ||
|
| ||||
Net (decrease) increase in cash and cash equivalent during the period | 67,547,214 | 52,907,679 | |||
Beginning balance of cash and cash equivalent | 233,912,193 |
| 92,895,143 | ||
Cash and cash equivalent at the end of the period |
| 301,459,407 |
| 145,802,822 | |
|
| ||||
Cash and cash equivalent comprise: |
|
|
| ||
Cash and balances at the central bank | 9 | 36,542,863 |
| 52,319,656 | |
Due from banks | 291,980,200 |
| 169,655,814 | ||
Treasury bills and other governmental notes | 11 | 119,754,167 | 68,681,151 | ||
Obligatory reserve balance with CBE | (19,383,018) |
| (45,888,981) | ||
Due from banks with maturity more than three months | (7,554,480) | (29,664,721) | |||
Treasury bills and other governmental notes with maturity more than three months | (119,880,325) | (69,300,097) | |||
Total cash and cash equivalent |
| 301,459,407 |
| 145,802,822 |
Condensed Separate Interim statement of changes in shareholders' equity | ||||||||||
| Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total |
Mar. 31, 2023 | ||||||||||
Beginning
Balance at 1 Januray 2023 | 29,825,134 | 3,963,946 | 27,096,858 | 1,549,445 | 18,947 | (13,138,461) | 11,981 | 16,497,346 | 1,895,435 | 67,720,631 |
Capital increase | 165,429 | - | - | - | - | - | - | - | - | 165,429 |
Transferred to reserves | - | 806,408 | 11,998,639 | - | 2,208 | - | - | (12,388,223) | (419,032) | - |
Dividend paid | - | - | - | - | - | - | - | (3,738,888) | - | (3,738,888) |
Net profit for the period | - | - | - | - | - | - | - | 6,084,453 | - | 6,084,453 |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | (1,895) | - | 1,895 | - | - |
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | (8,507,038) | - | - | - | (8,507,038) |
Transferred (from) to bank risk reserve | - | - | - | - | - | - | 3,249 | (3,249) | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | 208,250 | - | - | - | 208,250 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | 190,974 | 190,974 |
Balance at 31 March 2023 | 29,990,563 | 4,770,354 | 39,095,497 | 1,549,445 | 21,155 | (21,439,144) | 15,230 | 6,453,334 | 1,667,377 | 62,123,811 |
Mar. 31, 2024 |
|
|
|
|
|
|
|
|
|
|
Beginning Balance at 1 Januray 2024 | 30,195,010 | 4,770,354 | 39,840,707 | 1,549,445 | 21,155 | (16,808,265) | 15,230 | 29,230,360 | 1,486,010 | 90,300,006 |
Capital increase | - | - | - | - | - | - | - | - | - | - |
Transferred to reserves | - | 1,438,320 | 21,958,960 | - | 1,663 | - | - | (23,398,943) | - | - |
Dividend paid | - | - | - | - | - | - | - | (5,366,429) | - | (5,366,429) |
Net profit for the period | - | - | - | - | - | - | - | 11,946,597 | - | 11,946,597 |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | - | - | - |
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | 1,977,715 | - | - | - | 1,977,715 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | 2,694 | (2,694) | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | 745,406 | - | - | - | 745,406 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | 300,000 | 300,000 |
Balance at 31 March 2024 | 30,195,010 | 6,208,674 | 61,799,667 | 1,549,445 | 22,818 | (14,085,144) | 17,924 | 12,408,891 | 1,786,010 | 99,903,295 |
Related Shares:
Com.int.bk.regs